237690.KQ
ST Pharm Co.,Ltd.
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 99,000.00
−2.17%Margins
Gross margin
38.8%
EBITDA margin
27.0%
EBIT margin
18.3%
Net margin
19.9%
FCF margin
20.3%
12.2%
Return on equity
9.1%
Return on assets
10.0%
Return on invested capital
0.46x
Asset turnover
KRW 113.8B
Cash from operations
KRW 8.8K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026